WHO ICTRP trial
Combination of percutaneous fiber-optic intratumoral photodynamic therapy with…
ChiCTR2100053067 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100053067 |
|---|---|
| Public title | Combination of percutaneous fiber-optic intratumoral photodynamic therapy with immune checkpoint inhibitor in the treatment of hepatocellular carcinoma |
| Scientific title | Combination of percutaneous fiber-optic intratumoral photodynamic therapy with immune checkpoint inhibitor in the treatment of hepatocellular carcinoma |
| Primary sponsor | The Second Affiliated Hospital of Harbin Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | Hepatocellular carcinoma (HCC) |
| Interventions | Experimental group:Photodynamic interventional therapy |
| Registration date | Nov 10, 2021 |
| Target size | Experimental group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: